Seek and destroy: Development of novel viral therapy for EGFR-expressing tumors

• Christine O’Connor,
• Justin D. Lathia

Affiliations

Christine O’Connor

Department of Infection Biology, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA; Department of Molecular Medicine, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH, USA; Case Comprehensive Cancer Center, Cleveland, OH, USA; Corresponding author: Christine O’Connor, PhD, Department of Infection Biology, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA.

Justin D. Lathia

Department of Molecular Medicine, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH, USA; Case Comprehensive Cancer Center, Cleveland, OH, USA; Department of Cardiovascular & Metabolic Sciences, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA; Rose Ella Burkhardt Brain Tumor and Neuro-Oncology Center, Cleveland Clinic, Cleveland, OH, USA; Corresponding author: Justin D. Lathia, PhD, Department of Molecular Medicine, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH, USA.